Well Done LLC’s GSK GSK Stock Holding History

Well Done LLC’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-553	Closed	-$26K	–	351
2018 Q4	$26K	Buy	+553	New	+$27.2K	0.01%	317
2018 Q2	–	Sell	-499	Closed	-$24K	–	283
2018 Q1	$24K	Buy	+499	New	+$23.2K	0.01%	305

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Well Done LLC's GSK Position: Q1 2019 in Review

Well Done LLC sold out of GSK (GSK) in Q1 2019, closing a stake of 553 shares — an estimated $26K sold.

Well Done LLC first reported a position in GSK in Q1 2018 and held it in 2 quarters. The position peaked at $26K in Q4 2018. 847 funds tracked by Wall St. Rank hold GSK as of Q1 2019.

Well Done LLC reported no remaining GSK position as of Q1 2019 after selling out during the quarter.
Well Done LLC sold 553 GSK shares in Q1 2019, an estimated $26K.
Well Done LLC first reported a position in GSK in Q1 2018 and held it in 2 quarters.
Well Done LLC's GSK position peaked at $26K in Q4 2018.
847 funds tracked by Wall St. Rank held GSK as of Q1 2019.

Based on Well Done LLC's 13F filing for Q1 2019, filed 9 May 2019.